Mode
Text Size
Log in / Sign up
N/A N=276 Randomized Double-blind Treatment

Project Activate: Mindfulness and Acceptance Based Behavioral Treatment for Weight Loss

Obesity · Weight Loss

Enrolled (actual)
276
Serious AEs
0.7%
Results posted
Mar 2026
Primary outcome: Primary: Weight Change — 7.93; 9.17; 8.19; 9.36 percentage of weight change

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Behavioral Treatment (Behavioral); Willingness (Behavioral); Values (Behavioral); Mindful Awareness (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Drexel University
Primary completion
Nov 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Weight Change
7.93; 9.17; 8.19; 9.36; 9.11; 7.71
SECONDARY
Dietary Intake
1711.33; 1437.44; 1571.25; 1260.20; 1633.52; 1664.37
SECONDARY
Physical Activity
230.64; 222.57; 231.49; 195.98; 173.01; 222.94
SECONDARY
Quality of Life Score
10.85; 10.36; 11.01; 10.58; 10.50; 10.52

Summary

Mindfulness and Acceptance based Behavioral Therapies (MABTs) are among the most promising behavioral approaches for obesity, with two recent large trials showing that they achieve better initial weight loss and/or better weight loss maintenance than does gold standard behavioral weight loss treatment (BT). However, results vary, potentially due to inconsistencies in how MABT components are utilized and emphasized. Optimizing MABTs using a typical approach, i.e., successive randomized controlled trials of various MABT packages, is slow and difficult. Multiphase Optimization Strategy (MOST) has been developed as a better method of optimizing treatment. Consistent with Phase I of MOST, we derived three MABT components from the theoretical literature. Evaluation of MABT components through a factorial design (MOST Phase II) will allow us to determine the independent and interacting efficacies of each MABT component, in addition to the identification of subsets of individuals most or least responsive to each component. Whereas mediational analyses have been inconclusive, the use of a factorial design will allow for a critical test of the main and interaction effects of individual MABT treatment components. The current study will use a full factorial design to identify the independent and combined effects of three core MABT components (Awareness, Acceptance, and Values Clarity) as additions to remotely delivered weight loss counseling. Moderators of treatment outcome (disinhibited eating, food cue susceptibility, emotional eating, delay discounting, and inhibitory control), and mediator/process variables implicated in MABTs (mindful eating, acceptance of food cues, mindfulness, body responsiveness, autonomous motivation, values clarity, hunger/satiety perceptions, and motivation and pleasure resulting from social functioning) will be assessed as well.

Eligibility Criteria

Inclusion Criteria

  • Individuals must be of overweight or obese BMI (27-50 kg/m2)
  • Individuals must be adults (aged 18-70)
  • Completion of a 3-day food diary
  • Completion of baseline assessment tasks
  • Willingness to lose weight, be physically active, and participate in-group sessions.
  • Participants must also provide consent for the research team to contact their personal physician if necessary to provide clearance or to consult about rapid weight gain.

Exclusion Criteria

  • Inability to engage in physical activity (defined as walking a city block without stopping)
  • Medical or psychiatric condition that may pose a risk to the participant during intervention, cause a change in weight, or limit ability to comply with the program
  • Recently began or changed the dose of a medication that can cause significant change in weight
  • History of bariatric surgery; weight loss of > 5% in the previous 3 months
  • Currently pregnant or breastfeeding or planning to become pregnant
  • Planning to, or participating in, another weight loss treatment in the next 3 years.
  • Engaging in compensatory vomiting, other severe compensatory behaviors, or more than 12 of any compensatory behavior in the previous 3 months
  • Experiencing significant loss of control eating (9 or more binge episodes in the previous 3 months)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04337619). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search